Sort
4,870 grants matching “glp 1”
A Human Laboratory Study of Exenatide for Reducing the Reinforcing Effects of Cocaine
$199,265Christopher D Verrico · Baylor College Of Medicine · R21 · FY2024 · DA
Experimental Mouse
$199,260Natalia A Ignatenko · University Of Arizona · P30 · FY2020 · CA
AWARE Project 3: Utilization, effectiveness, safety, and persistence of GLP-IRA and LAAR therapies among people living with and without HIV
$199,151Christopher T. Rentsch · Yale University · P60 · FY2025 · AA
Small Animal Phenotyping Core
$198,795Barbara A. Gower · University Of Alabama At Birmingham · P30 · FY2008 · DK
Development of N-tert-(Butyl)hydroxylamine (NtBuHA) as a therapeutic agent for treating Infantile Neuronal Ceroid Lipofuscinosis (INCL)
$198,790Andrew Lim · Circumvent Pharmaceuticals, Inc. · R43 · FY2017 · NS
Bioanalytical Core
$198,359Pedro A. Jose · Children'S Research Institute · U54 · FY2014 · HD
Exploring Mechanisms of Changes in Glucose Homeostasis After Bariatric Surgery: Comparing Vertical Sleeve Gastrectomy and Roux-en-Y Gastric Bypass
$198,305Clare Jung Eun Lee · Johns Hopkins University · K23 · FY2017 · DK
Exploring Mechanisms of Changes in Glucose Homeostasis After Bariatric Surgery: Comparing Vertical Sleeve Gastrectomy and Roux-en-Y Gastric Bypass
$198,305Clare Jung Eun Lee · Johns Hopkins University · K23 · FY2018 · DK
Translational Biomarker Analytical Core
$198,048Blandine B Laferrere · Columbia University Health Sciences · P30 · FY2024 · DK
Experimental Mouse
$197,749Natalia A Ignatenko · University Of Arizona · P30 · FY2016 · CA
ProHealing Drug Alternative for Coronary Drug Eluting Stents
$197,725Patrick Sl Wong · Prolude Medical, Inc. · R43 · FY2012 · HL
Pancreatic alpha-cells and Maternal metabolic Adaptation
$197,500Jianhua Shao · University Of California, San Diego · R21 · FY2024 · HD
Alpha cell-derived Extracellular Vesicles and Maternal Insulin Production
$197,500Jianhua Shao · University Of California, San Diego · R21 · FY2024 · HD
Validation of a Human In Vitro Vaginal Irritation Test
$197,217Seyoum Ayehunie · Mattek Corporation · R44 · FY2011 · HD
Clinical Translation of a Neuron Protective Recombinant Human Antibody
$197,125Moses Rodriguez · Mayo Clinic Rochester · R21 · FY2012 · NS
H3K9 Methylation and Pancreatic Cancer Chemoresistance
$196,947Kebin Liu · Augusta University · R21 · FY2014 · CA
Encapsulated cells to treat type 1 diabetes
$196,891William R Osborne · University Of Washington · R01 · FY2006 · DK
Does GPR119 mediate the beneficial metabolic effects of THC?
$196,875Kenneth P. Mackie · Trustees Of Indiana University · R21 · FY2018 · DA
Does GPR119 mediate the beneficial metabolic effects of THC?
$196,406Kenneth P. Mackie · Trustees Of Indiana University · R21 · FY2017 · DA
Mechanisms of Enteroendocrine L-Cell Dysfunction and Bile Adaptations to Weight Loss
$196,029Andres J Acosta · Mayo Clinic Rochester · K23 · FY2022 · DK
Mechanisms of Enteroendocrine L-Cell Dysfunction and Bile Adaptations to Weight Loss
$195,931Andres J Acosta · Mayo Clinic Rochester · K23 · FY2021 · DK
Mechanisms of Enteroendocrine L-Cell Dysfunction and Bile Adaptations to Weight Loss
$195,931Andres J Acosta · Mayo Clinic Rochester · K23 · FY2019 · DK
Mechanisms of Enteroendocrine L-Cell Dysfunction and Bile Adaptations to Weight Loss
$195,931Andres J Acosta · Mayo Clinic Rochester · K23 · FY2020 · DK
Mechanisms of Enteroendocrine L-Cell Dysfunction and Bile Adaptations to Weight Loss
$195,832Andres J Acosta · Mayo Clinic Rochester · K23 · FY2018 · DK
Intravenous Protein Therapy for Myotonic Dystrophy Type 1
$195,590Dustin Armstrong · Valerion Therapeutics, Llc · R21 · FY2010 · NS